secwatch.observer — SEC 8-K summary
======================================

Issuer:     HOLOGIC INC (—)
CIK:        0000859737
Form:       8-K
Filed at:   2024-05-02T23:59:59+00:00
Accession:  0001140361-24-023989
Event type: earnings
Sentiment:  positive
Materiality: 0.80
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Hologic beats Q2 guidance; raises FY2024 revenue & EPS outlook; acquires Endomagnetics for $310M
--------------------------------------------------------------------------------

- Revenue $1,017.8M (-0.8% YoY); GAAP EPS $0.72, Non-GAAP EPS $1.03, both above guidance.
- Organic revenue ex-COVID grew 4.9% constant currency; Diagnostics ex-COVID +9.8%, Surgical +7.7%.
- Raised FY2024 revenue midpoint (constant currency) and EPS guidance on strong margins.
- Agreed to acquire Endomagnetics Ltd for ~$310M to expand interventional breast business.
- Operating cash flow $292.4M in Q2; cash flow from operations remains strong.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/859737/000114036124023989/0001140361-24-023989-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/859737/000114036124023989/ef20028283_8k.htm
  HTML page:      https://secwatch.observer/filing/0001140361-24-023989

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer